查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2094028

全球人工智慧臨床記錄（環境抄寫員）市場：按產品、部署、功能、醫療環境、最終用戶和地區分類－市場規模、產業動態、機會分析和預測（2026-2035 年）

Global AI Clinical Documentation (Ambient Scribe) Market By Offering, Deployment, Capability, Care Setting, End User, Region - Market Size, Industry Dynamics, Opportunity Analysis and Forecast For 2026-2035
出版日期: | 出版商: Astute Analytica | 英文 | 商品交期: 最快1-2個工作天內

價格
簡介目錄

隨著醫療機構擴大採用人工智慧解決方案來應對日益嚴峻的病歷創建挑戰並提高臨床營運效率，人工智慧驅動的病歷創建市場正在迅速擴張。預計到2025年，該市場規模將達到約12億美元，並預計在2035年顯著成長至約151億美元。這意味著在2026年至2035年的預測期內，該市場將以28.8%的複合年成長率成長。

隨著人們越來越重視簡化文件流程，Ambient Scribe 技術在醫院、醫療系統和專科診所的應用正在加速。傳統的文件記錄方式需要醫生手動將大量詳細資訊輸入電子病歷 (EHR) 平台，這降低了工作效率，並增加了記錄延遲或不完整的可能性。而人工智慧驅動的文件系統則利用先進的語音辨識、自然語言處理和生成式人工智慧技術，自動將醫病對話轉化為結構化的醫療記錄。

顯著的市場趨勢

人工智慧驅動的臨床文件（Ambient Scribe）市場競爭日益激烈，多家領先的技術供應商憑藉先進的人工智慧功能、與醫療系統的整合以及企業級部署，迅速佔據了市場主導地位。微軟的Nuance DAX Copilot憑藉其廣泛的醫療基礎設施和強大的整合能力，正在成為大規模企業醫院系統中的主流解決方案。

Abridge專注於研發和高精度醫療記錄生成，已成為企業級環境環境的領先供應商。 Commure Scribe也是市場上的重要參與者，其產品被廣泛採用，每年支援數百萬次的患者諮詢。其平台因在高患者量醫療環境中提供可擴展的、人工智慧驅動的文檔解決方案而備受讚譽。

S10.ai CRUSH 的獨特之處在於其專注於先進的環境智慧和在多個醫療專科領域的廣泛應用。 DeepScribe 已在腫瘤學和循環系統等複雜的專科醫療領域確立了強大的市場地位，這些領域需要詳盡的醫學知識和專業術語來進行臨床記錄。

主要成長要素

與臨床文件相關的日益繁重的行政負擔，仍然是推動全球人工智慧驅動的臨床文件（Ambient Scribe）市場擴張的最強勁動力之一。醫療專業人員越來越需要記錄與患者的每一次互動，包括病歷、身體檢查觀察、診斷、治療方案、用藥記錄和後續觀察指導。雖然全面的文檔記錄對於確保醫療服務的連續性、符合監管要求以及獲得保險報銷至關重要，但它卻佔用了醫生大量的工作時間。隨著文件記錄要求的不斷成長，醫療機構正在積極尋求能夠減輕行政負擔的技術，使臨床醫生能夠將更多時間投入直接的患者護理。

新機會的趨勢

生成式人工智慧 (AI) 與大規模語言模型 (LLM) 的融合正成為全球 AI 驅動的臨床文件（環境記錄系統）市場最重要的成長機會之一。隨著生成式 AI 的不斷進步，環境記錄系統正從簡單的語音轉文字工具轉型為智慧臨床助手，能夠理解醫療環境中的對話、解讀臨床背景並創建全面的文件。隨著醫療機構尋求既能減輕管理負擔又能提高文件品質的解決方案，基於 LLM 的環境記錄系統平台的普及預計將顯著加速。

最佳化障礙

大規模語言模型（LLM）的臨床風險和固有變異性構成重大挑戰，可能阻礙人工智慧驅動的臨床文件（環境記錄）市場的發展。儘管環境人工智慧技術顯著提高了文件效率和臨床醫生的工作效率，但對準確性、可靠性和病人安全的擔憂仍然限制了其在臨床環境中的廣泛應用。由於醫療文件直接影響診斷、治療計劃、護理協調、合規性和保險報銷，即使是微小的文檔錯誤也可能造成嚴重後果。因此，醫療機構在實施人工智慧驅動的文件系統時仍然保持謹慎，尤其是在準確性至關重要的高風險臨床環境中。

目錄

第1章執行摘要：全球人工智慧臨床記錄（Ambient Scribe）市場

第2章：調查方法與研究框架

  • 研究目標
  • 產品概述
  • 市場區隔
  • 定性研究
    • 一手和二手資訊
  • 量化研究
    • 一手和二手資訊
  • 主要調查受訪者組成：按地區分類
  • 本研究的前提
  • 市場規模估算
  • 數據三角測量

第3章：全球人工智慧臨床記錄（Ambient Scribe）市場概述

  • 產業價值鏈分析
  • 產業展望
    • 全球環境人工智慧臨床文件產業概覽
    • 減少醫師職業倦怠，實現醫療記錄自動化，並與電子病歷系統原生整合。
    • HIPAA/同意、資料安全管治和編碼/收入完整性
  • PESTLE分析
  • 波特五力分析
  • 市場成長及前景
    • 2020-2035年市場收入估算與預測
    • 價格趨勢分析：透過報價

第4章：全球人工智慧臨床記錄（Ambient Scribe）市場分析

  • 競爭對手儀錶板
    • 市場集中度
    • 企業市場占有率分析，2025 年
    • 競爭對手分析與基準測試

第5章：全球人工智慧臨床記錄（Ambient Scribe）市場分析

  • 市場動態和趨勢
    • 成長要素
    • 抑制因子
    • 機會
    • 主要趨勢
  • 市場規模及預測，2020-2035年
    • 報價
      • 關鍵見解
        • 軟體/平台
        • 服務
          • 執行
          • 管理
    • 不同的發展
      • 關鍵見解
        • 雲
        • 本地部署/混合部署
    • 按功能
      • 關鍵見解
        • 筆記生成
        • 醫療編碼和計費
        • 處方箋和轉診信的準備
        • 電子健康記錄 (EHR) 整合
    • 透過護理環境
      • 關鍵見解
        • 門診治療
        • 住院治療
        • 緊急狀況
        • 遠端醫療
        • 專科診所
    • 最終用戶
      • 關鍵見解
        • 醫院和醫療保健系統
        • 私人執業者
        • 付款人
    • 按地區
      • 關鍵見解
        • 北美洲
          • 美國
          • 加拿大
          • 墨西哥
        • 歐洲
          • 西歐
            • 英國
            • 德國
            • 法國
            • 義大利
            • 西班牙
            • 其他西歐國家
          • 東歐
            • 波蘭
            • 俄羅斯
            • 其他東歐國家
        • 亞太地區
          • 中國
          • 印度
          • 日本
          • 澳洲和紐西蘭
          • 韓國
          • ASEAN
          • 其他亞太國家
        • 中東和非洲（MEA）
          • 沙烏地阿拉伯
          • 南非
          • UAE
          • 其他中東和非洲國家
        • 南美洲
          • 阿根廷
          • 巴西
          • 其他南美國家

第6章：北美市場分析

第7章：歐洲市場分析

第8章：亞太市場分析

第9章：中東和非洲市場分析

第10章：南美市場分析

第11章：公司簡介

  • Abridge
  • Microsoft（Nuance DAX Copilot）
  • Ambience Healthcare
  • Suki
  • Nabla
  • Commure/Athelas
  • DeepScribe
  • Corti
  • Augmedix
  • Oracle Health
  • Epic（integrated）
  • Solventum（3M HIS）
  • Sunoh.ai
  • Tali AI
  • Heidi Health
  • 其他主要公司

第12章附錄

簡介目錄
Product Code: AA07261873

The AI clinical documentation market is undergoing rapid expansion as healthcare organizations increasingly adopt artificial intelligence-powered solutions to address growing documentation challenges and improve clinical efficiency. The market is estimated to reach approximately USD 1.2 billion in 2025 and is projected to expand significantly to around USD 15.1 billion by 2035, reflecting a strong compound annual growth rate (CAGR) of 28.8% during the forecast period from 2026 to 2035.

The growing emphasis on documentation efficiency is accelerating the adoption of ambient scribe technologies across hospitals, health systems, and specialty practices. Traditional documentation methods require physicians to manually enter extensive details into EHR platforms, which can reduce workflow efficiency and increase the likelihood of delayed or incomplete records. AI-powered documentation systems leverage advanced speech recognition, natural language processing, and generative artificial intelligence to automatically transform clinician-patient conversations into structured medical notes.

Noteworthy Market Developments

The AI clinical documentation (ambient scribe) market is becoming increasingly competitive, with several leading technology providers establishing strong positions through advanced artificial intelligence capabilities, healthcare integrations, and enterprise-scale deployments. Microsoft's Nuance DAX Copilot has emerged as a dominant solution among large enterprise hospital systems due to its extensive healthcare infrastructure and deep integration capabilities.

Abridge has established itself as a leading enterprise-focused ambient documentation provider by emphasizing research-driven development and highly accurate clinical note generation. Commure Scribe represents another major player with substantial market adoption, supporting millions of patient encounters annually. The platform has gained recognition for its ability to deliver scalable AI-powered documentation solutions across healthcare environments with high patient volumes.

S10.ai CRUSH differentiates itself through its focus on advanced ambient intelligence and broad adaptability across multiple medical specialties. DeepScribe has developed a strong position in complex specialty practices, particularly in fields such as oncology and cardiology, where clinical documentation requires detailed medical knowledge and specialized terminology.

Core Growth Drivers

The growing administrative burden associated with clinical documentation remains one of the strongest factors driving the expansion of the global AI clinical documentation (ambient scribe) market. Healthcare professionals are increasingly required to complete extensive documentation for every patient encounter, including medical histories, physical examination findings, diagnoses, treatment plans, medication records, and follow-up instructions. While comprehensive documentation is essential for ensuring continuity of care, regulatory compliance, and reimbursement, it also consumes a significant portion of physicians' working hours. As documentation requirements continue to increase, healthcare organizations are actively seeking technologies that can reduce administrative workloads while allowing clinicians to devote more time to direct patient care.

Emerging Opportunity Trends

The integration of generative artificial intelligence (AI) and large language models (LLMs) is emerging as one of the most significant growth opportunities in the global AI clinical documentation (ambient scribe) market. Continuous advancements in generative AI have transformed ambient documentation systems from basic speech-to-text transcription tools into intelligent clinical assistants capable of understanding medical conversations, interpreting clinical context, and producing comprehensive documentation. As healthcare providers seek solutions that reduce administrative burden while improving documentation quality, the adoption of LLM-powered ambient scribe platforms is expected to accelerate significantly.

Barriers to Optimization

Clinical risk and the inherent variability of large language models (LLMs) represent significant challenges that may restrain the growth of the AI clinical documentation (ambient scribe) market. Although ambient AI technologies offer substantial improvements in documentation efficiency and clinician productivity, concerns regarding accuracy, reliability, and patient safety continue to limit widespread adoption in clinical practice. Healthcare documentation directly influences diagnosis, treatment decisions, care coordination, regulatory compliance, and insurance reimbursement, making even minor documentation errors potentially consequential. As a result, healthcare organizations remain cautious when implementing AI-powered documentation systems, particularly in high-risk clinical environments where accuracy is essential.

Detailed Market Segmentation

By deployment mode, cloud-based deployment emerged as the leading segment in the global AI clinical documentation (ambient scribe) market, accounting for 51.35% of the market share in 2025. The growing preference for cloud deployment is driven by its ability to provide scalable computing resources, flexible infrastructure, and seamless access to advanced artificial intelligence capabilities. As healthcare organizations increasingly adopt AI-powered clinical documentation solutions, cloud platforms have become the preferred deployment model.

By capability, automated note generation emerged as the largest segment in the global AI clinical documentation (ambient scribe) market, accounting for 53.34% of the market share in 2025. This leadership is primarily attributed to the capability to address one of the most significant operational challenges in modern healthcare-the extensive time clinicians spend on clinical documentation. As healthcare systems increasingly adopt artificial intelligence to improve efficiency, automated note generation has become a core feature of ambient scribe platforms, enabling healthcare providers to create accurate, structured, and comprehensive clinical notes with minimal manual effort.

By care setting, the inpatient care segment emerged as the leading contributor to the AI clinical documentation (ambient scribe) market, accounting for 61.55% of the global market share in 2025. This dominance is primarily driven by the highly complex nature of inpatient healthcare delivery, where patients require continuous monitoring, multidisciplinary treatment, and extensive clinical documentation throughout their hospital stay. Unlike outpatient settings, inpatient care involves prolonged interactions among physicians, nurses, specialists, pharmacists, and other healthcare professionals, resulting in a substantial volume of clinical records that must be accurately documented and updated in real time.

By end user, hospitals and large integrated health systems accounted for the largest share of the AI clinical documentation (ambient scribe) market, representing 55.13% of the global market in 2025. Their dominant position is primarily attributed to the scale and complexity of their healthcare operations, which generate a high volume of clinical documentation across multiple specialties and care settings. These organizations manage extensive networks of hospitals, outpatient clinics, specialty centers, emergency departments, and affiliated physician practices, creating significant demand for efficient and standardized documentation solutions.

Segment Breakdown

By Offering

  • Software/Platform
  • Services
  • Implementation
  • Managed

By Deployment

  • Cloud
  • On-Premises/Hybrid

By Capability

  • Note Generation
  • Medical Coding & Billing
  • Order & Referral Drafting
  • EHR Integration

By Care Setting

  • Ambulatory/Outpatient
  • Inpatient, Emergency
  • Telehealth
  • Specialty Clinics

By End User

  • Hospitals & Health Systems
  • Physician Practices
  • Payers

By Region

  • North America
  • The U.S.
  • Canada
  • Mexico
  • Europe
  • Western Europe
  • The UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Western Europe
  • Eastern Europe
  • Poland
  • Russia
  • Rest of Eastern Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia & New Zealand
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East & Africa (MEA)
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of MEA
  • South America
  • Argentina
  • Brazil
  • Rest of South America

Geography Breakdown

  • North America accounts for nearly half of the global ambient scribe market, primarily because of its well-established healthcare information technology infrastructure and widespread adoption of electronic health record (EHR) systems. Healthcare providers across the United States and Canada have invested heavily in digital transformation over the past decade, creating an environment where advanced technologies such as ambient clinical documentation can be integrated efficiently.
  • Large healthcare organizations throughout North America consistently prioritize substantial investments in innovative software technologies to improve operational efficiency, enhance patient outcomes, and reduce administrative burdens on healthcare professionals. Hospitals, integrated delivery networks, and multi-specialty clinics allocate significant financial resources toward adopting artificial intelligence-driven solutions that can optimize clinical workflows.
  • Another important factor supporting market leadership is the region's strict regulatory environment, which requires healthcare providers to maintain accurate, complete, and standardized patient records. Regulatory frameworks governing healthcare documentation and medical insurance reimbursement emphasize the importance of precise clinical records to ensure compliance, minimize claim denials, and support quality assurance initiatives.

Leading Market Participants

  • Abridge
  • Microsoft (Nuance DAX Copilot)
  • Ambience Healthcare
  • Suki
  • Nabla
  • Commure/Athelas
  • DeepScribe
  • Corti
  • Augmedix
  • Oracle Health
  • Epic (integrated)
  • Solventum (3M HIS)
  • Sunoh.ai
  • Tali AI
  • Heidi Health
  • Other Prominent Players

Table of Content

Chapter 1. Executive Summary: Global AI Clinical Documentation (Ambient Scribe) Market

Chapter 2. Research Methodology & Research Framework

  • 2.1. Research Objective
  • 2.2. Product Overview
  • 2.3. Market Segmentation
  • 2.4. Qualitative Research
    • 2.4.1. Primary & Secondary Sources
  • 2.5. Quantitative Research
    • 2.5.1. Primary & Secondary Sources
  • 2.6. Breakdown of Primary Research Respondents, By Region
  • 2.7. Assumption for Study
  • 2.8. Market Size Estimation
  • 2.9. Data Triangulation

Chapter 3. Global AI Clinical Documentation (Ambient Scribe) Market Overview

  • 3.1. Industry Value Chain Analysis
    • 3.1.1. Speech-Recognition, LLM & Foundation-Model Providers
    • 3.1.2. Ambient-Scribe Platform & Clinical-NLP Developers
    • 3.1.3. EHR Vendors & Interoperability (FHIR / HL7) Integrators
    • 3.1.4. Implementation, Managed-Service & Revenue-Cycle Partners
    • 3.1.5. End Users (Hospitals & Health Systems, Physician Practices, Payers)
  • 3.2. Industry Outlook
    • 3.2.1. Overview of the Global Ambient AI Clinical Documentation Industry
    • 3.2.2. Physician-Burnout Relief, Note Automation & EHR-Native Integration
    • 3.2.3. HIPAA / Consent, Data-Security Governance & Coding / Revenue-Integrity
  • 3.3. PESTLE Analysis
  • 3.4. Porter's Five Forces Analysis
    • 3.4.1. Bargaining Power of Suppliers
    • 3.4.2. Bargaining Power of Buyers
    • 3.4.3. Threat of Substitutes
    • 3.4.4. Threat of New Entrants
    • 3.4.5. Degree of Competition
  • 3.5. Market Growth and Outlook
    • 3.5.1. Market Revenue Estimates and Forecast (US$ Mn), 2020-2035
    • 3.5.2. Price Trend Analysis, By Offering

Chapter 4. Global AI Clinical Documentation (Ambient Scribe) Market Analysis

  • 4.1. Competition Dashboard
    • 4.1.1. Market Concentration Rate
    • 4.1.2. Company Market Share Analysis (Value %), 2025
    • 4.1.3. Competitor Mapping & Benchmarking

Chapter 5. Global AI Clinical Documentation (Ambient Scribe) Market Analysis

  • 5.1. Market Dynamics and Trends
    • 5.1.1. Growth Drivers
    • 5.1.2. Restraints
    • 5.1.3. Opportunity
    • 5.1.4. Key Trends
  • 5.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 5.2.1. By Offering
      • 5.2.1.1. Key Insights
        • 5.2.1.1.1. Software/Platform
        • 5.2.1.1.2. Services
          • 5.2.1.1.2.1. Implementation
          • 5.2.1.1.2.2. Managed
    • 5.2.2. By Deployment
      • 5.2.2.1. Key Insights
        • 5.2.2.1.1. Cloud
        • 5.2.2.1.2. On-Premises/Hybrid
    • 5.2.3. By Capability
      • 5.2.3.1. Key Insights
        • 5.2.3.1.1. Note Generation
        • 5.2.3.1.2. Medical Coding & Billing
        • 5.2.3.1.3. Order & Referral Drafting
        • 5.2.3.1.4. EHR Integration
    • 5.2.4. By Care Setting
      • 5.2.4.1. Key Insights
        • 5.2.4.1.1. Ambulatory/Outpatient
        • 5.2.4.1.2. Inpatient
        • 5.2.4.1.3. Emergency
        • 5.2.4.1.4. Telehealth
        • 5.2.4.1.5. Specialty Clinics
    • 5.2.5. By End User
      • 5.2.5.1. Key Insights
        • 5.2.5.1.1. Hospitals & Health Systems
        • 5.2.5.1.2. Physician Practices
        • 5.2.5.1.3. Payers
    • 5.2.6. By Region
      • 5.2.6.1. Key Insights
        • 5.2.6.1.1. North America
          • 5.2.6.1.1.1. The U.S.
          • 5.2.6.1.1.2. Canada
          • 5.2.6.1.1.3. Mexico
        • 5.2.6.1.2. Europe
          • 5.2.6.1.2.1. Western Europe
            • 5.2.6.1.2.1.1. The UK
            • 5.2.6.1.2.1.2. Germany
            • 5.2.6.1.2.1.3. France
            • 5.2.6.1.2.1.4. Italy
            • 5.2.6.1.2.1.5. Spain
            • 5.2.6.1.2.1.6. Rest of Western Europe
          • 5.2.6.1.2.2. Eastern Europe
            • 5.2.6.1.2.2.1. Poland
            • 5.2.6.1.2.2.2. Russia
            • 5.2.6.1.2.2.3. Rest of Eastern Europe
        • 5.2.6.1.3. Asia Pacific
          • 5.2.6.1.3.1. China
          • 5.2.6.1.3.2. India
          • 5.2.6.1.3.3. Japan
          • 5.2.6.1.3.4. Australia & New Zealand
          • 5.2.6.1.3.5. South Korea
          • 5.2.6.1.3.6. ASEAN
          • 5.2.6.1.3.7. Rest of Asia Pacific
        • 5.2.6.1.4. Middle East & Africa (MEA)
          • 5.2.6.1.4.1. Saudi Arabia
          • 5.2.6.1.4.2. South Africa
          • 5.2.6.1.4.3. UAE
          • 5.2.6.1.4.4. Rest of MEA
        • 5.2.6.1.5. South America
          • 5.2.6.1.5.1. Argentina
          • 5.2.6.1.5.2. Brazil
          • 5.2.6.1.5.3. Rest of South America

Chapter 6. North America Market Analysis

  • 6.1. Market Dynamics and Trends
    • 6.1.1. Growth Drivers
    • 6.1.2. Restraints
    • 6.1.3. Opportunity
    • 6.1.4. Key Trends
  • 6.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 6.2.1. Key Insights
      • 6.2.1.1. By Offering
      • 6.2.1.2. By Deployment
      • 6.2.1.3. By Capability
      • 6.2.1.4. By Care Setting
      • 6.2.1.5. By End User
      • 6.2.1.6. By Country

Chapter 7. Europe Market Analysis

  • 7.1. Market Dynamics and Trends
    • 7.1.1. Growth Drivers
    • 7.1.2. Restraints
    • 7.1.3. Opportunity
    • 7.1.4. Key Trends
  • 7.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 7.2.1. Key Insights
      • 7.2.1.1. By Offering
      • 7.2.1.2. By Deployment
      • 7.2.1.3. By Capability
      • 7.2.1.4. By Care Setting
      • 7.2.1.5. By End User
      • 7.2.1.6. By Country

Chapter 8. Asia Pacific Market Analysis

  • 8.1. Market Dynamics and Trends
    • 8.1.1. Growth Drivers
    • 8.1.2. Restraints
    • 8.1.3. Opportunity
    • 8.1.4. Key Trends
  • 8.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 8.2.1. Key Insights
      • 8.2.1.1. By Offering
      • 8.2.1.2. By Deployment
      • 8.2.1.3. By Capability
      • 8.2.1.4. By Care Setting
      • 8.2.1.5. By End User
      • 8.2.1.6. By Country

Chapter 9. Middle East & Africa Market Analysis

  • 9.1. Market Dynamics and Trends
    • 9.1.1. Growth Drivers
    • 9.1.2. Restraints
    • 9.1.3. Opportunity
    • 9.1.4. Key Trends
  • 9.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 9.2.1. Key Insights
      • 9.2.1.1. By Offering
      • 9.2.1.2. By Deployment
      • 9.2.1.3. By Capability
      • 9.2.1.4. By Care Setting
      • 9.2.1.5. By End User
      • 9.2.1.6. By Country

Chapter 10. South America Market Analysis

  • 10.1. Market Dynamics and Trends
    • 10.1.1. Growth Drivers
    • 10.1.2. Restraints
    • 10.1.3. Opportunity
    • 10.1.4. Key Trends
  • 10.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 10.2.1. Key Insights
      • 10.2.1.1. By Offering
      • 10.2.1.2. By Deployment
      • 10.2.1.3. By Capability
      • 10.2.1.4. By Care Setting
      • 10.2.1.5. By End User
      • 10.2.1.6. By Country

Chapter 11. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)

  • 11.1. Abridge
  • 11.2. Microsoft (Nuance DAX Copilot)
  • 11.3. Ambience Healthcare
  • 11.4. Suki
  • 11.5. Nabla
  • 11.6. Commure/Athelas
  • 11.7. DeepScribe
  • 11.8. Corti
  • 11.9. Augmedix
  • 11.10. Oracle Health
  • 11.11. Epic (integrated)
  • 11.12. Solventum (3M HIS)
  • 11.13. Sunoh.ai
  • 11.14. Tali AI
  • 11.15. Heidi Health
  • 11.16. Other Prominent Players

Chapter 12. Annexure

  • 12.1. List of Secondary Sources
  • 12.2. Key Country Markets- Macro Economic Outlook/Indicators